Poly Medicure Limited

Poly Medicure Ltd share price gained 0.13% to Rs 1708.85 after the company's net profit saw a strong growth of 31.10% to Rs 85.27 crore, while revenue from operations eased by 1.71% to Rs 525.38 crore in Q2FY26 over Q1FY26. The market capitalization of Medical Equipment & Supplies industry group stocks on BSE stood at Rs 23409.88 crore, gaining 2.96%. It has slipped by 0.13% over last one week and moved up slightly by 5.21% in last one month while the market capitalization of Poly Medicure Ltd has inched up 0.34% and 3.49% in the same period respectively. Profit before tax (PBT) of Poly Medicure Ltd stood at Rs 117.31 crore in Q2 FY26, declining 4.59% year-on-year, and jumping 37.66% quarter-on-quarter. EBITDA came in at Rs 92 crore, rallying 44.17% YoY and slipping 1.04% sequentially. Total expenses marginally dropped 5.58% to Rs 436.53 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 183.88 crore, going up by 18.57% YoY, while employee benefits expense was at Rs 126.9 crore, ticking higher by 0.60% YoY. For the TTM ended FY26, revenue from operations witnessed a strong growth of 21.37% to Rs 1669.83 crore, while net profit soared by 31.09% to Rs 338.56 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 31719% to Rs 363.71 crore, and PBT soared 31.44% to Rs 452.52 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 233.05 crore in FY26, as against Rs 266.08 crore in FY25. Poly Medicure Ltd nosedived by 12.69% in last one year, underperforming the benchmark BSE Sensex which has slipped by 1.97% during the same period.

Poly Medicure has appointed Indranil Mukherjee as Chief Executive Officer - Asia Pacific and India Business, Senior Management Personnel with effect from 01 June 2026.

Poly Medicure announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 70%) , subject to the approval of the shareholders.

Profit before tax (PBT) increased 30.63% YoY to Rs 85.22 crore in Q4 FY26. Operating EBITDA dropped 8% to Rs 112.1 crore in Q4 FY26 from Rs 121.9 crore posted in Q4 FY25. EBITDA margin contracted to 667 bps to 21% in Q4 FY26 as against 27.6% in Q4 FY25. Revenue from infusion therapy segment rose 1.9% YoY to Rs 256.1 crore while revenue from renal segment climbed 21.3% YoY to Rs 56.2 crore and revenue from others segment stood at Rs 222.1 crore, up 55.2% YoY. On full year basis, the company's consolidated net profit fell 4.85% to Rs 322.13 crore on 12.3% increase in revenue from operations to Rs 1,875.25 crore in FY26 over FY25. Meanwhile, the company's board recommended a dividend of Rs 3.5 per equity shares of Rs 5 each for the financial year 2025-26. Poly Medicure exports plastic medical disposables/surgical devices. It manufactures and supplies approximately 100 types of disposable medical devices in the product verticals of infusion therapy, anesthesia, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis and central venous access catheters.Powered by Capital Market - Live

Net profit of Poly Medicure declined 27.81% to Rs 66.29 crore in the quarter ended March 2026 as against Rs 91.83 crore during the previous quarter ended March 2025. Sales rose 21.25% to Rs 534.51 crore in the quarter ended March 2026 as against Rs 440.83 crore during the previous quarter ended March 2025. For the full year,net profit declined 4.85% to Rs 322.14 crore in the year ended March 2026 as against Rs 338.56 crore during the previous year ended March 2025. Sales rose 12.30% to Rs 1875.26 crore in the year ended March 2026 as against Rs 1669.83 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales534.51440.83 21 1875.261669.83 12 OPM %20.6527.10 -23.5927.12 - PBDT123.45143.88 -14 549.79535.15 3 PBT85.22122.85 -31 434.27452.52 -4 NP66.2991.83 -28 322.14338.56 -5 Powered by Capital Market - Live

Poly Medicure will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Net profit of Poly Medicure declined 16.78% to Rs 70.93 crore in the quarter ended December 2025 as against Rs 85.23 crore during the previous quarter ended December 2024. Sales rose 16.37% to Rs 493.66 crore in the quarter ended December 2025 as against Rs 424.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales493.66424.21 16 OPM %22.5226.97 - PBDT133.17134.59 -1 PBT104.41113.23 -8 NP70.9385.23 -17 Powered by Capital Market - Live

Poly Medicure will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live

Dr Agarwals Health Care Ltd, Nava Ltd, Trent Ltd, Redington Ltd are among the other stocks to see a surge in volumes on NSE today, 06 January 2026.Poly Medicure Ltd saw volume of 14.7 lakh shares by 14:14 IST on NSE, a 11.86 fold spurt over two-week average daily volume of 1.24 lakh shares. The stock increased 3.14% to Rs.1,778.40. Volumes stood at 96746 shares in the last session.Dr Agarwals Health Care Ltd notched up volume of 8.65 lakh shares by 14:14 IST on NSE, a 10.13 fold spurt over two-week average daily volume of 85357 shares. The stock rose 2.53% to Rs.512.75. Volumes stood at 59639 shares in the last session.Nava Ltd saw volume of 22.69 lakh shares by 14:14 IST on NSE, a 8.66 fold spurt over two-week average daily volume of 2.62 lakh shares. The stock increased 5.67% to Rs.616.30. Volumes stood at 4.22 lakh shares in the last session.Trent Ltd witnessed volume of 43.96 lakh shares by 14:14 IST on NSE, a 6.65 times surge over two-week average daily volume of 6.61 lakh shares. The stock dropped 8.40% to Rs.4,057.70. Volumes stood at 5.1 lakh shares in the last session.Redington Ltd witnessed volume of 84.04 lakh shares by 14:14 IST on NSE, a 5.11 times surge over two-week average daily volume of 16.46 lakh shares. The stock increased 3.25% to Rs.287.50. Volumes stood at 13.72 lakh shares in the last session.Powered by Capital Market - Live

Syrma SGS Technology Ltd, Transformers & Rectifiers India Ltd, HEG Ltd, K E C International Ltd are among the other stocks to see a surge in volumes on NSE today, 11 November 2025.Poly Medicure Ltd clocked volume of 23.67 lakh shares by 14:14 IST on NSE, a 22.16 times surge over two-week average daily volume of 1.07 lakh shares. The stock gained 11.15% to Rs.2,070.00. Volumes stood at 1.18 lakh shares in the last session.Syrma SGS Technology Ltd clocked volume of 178.41 lakh shares by 14:14 IST on NSE, a 14.45 times surge over two-week average daily volume of 12.35 lakh shares. The stock gained 3.34% to Rs.835.00. Volumes stood at 12.05 lakh shares in the last session.Transformers & Rectifiers India Ltd saw volume of 235.21 lakh shares by 14:14 IST on NSE, a 13.5 fold spurt over two-week average daily volume of 17.42 lakh shares. The stock dropped 9.63% to Rs.283.35. Volumes stood at 32.29 lakh shares in the last session.HEG Ltd witnessed volume of 227.08 lakh shares by 14:14 IST on NSE, a 9.84 times surge over two-week average daily volume of 23.07 lakh shares. The stock increased 3.89% to Rs.539.50. Volumes stood at 15.31 lakh shares in the last session.K E C International Ltd registered volume of 53.21 lakh shares by 14:14 IST on NSE, a 9.64 fold spurt over two-week average daily volume of 5.52 lakh shares. The stock rose 5.32% to Rs.760.65. Volumes stood at 12.77 lakh shares in the last session.Powered by Capital Market - Live